Login / Signup

Genomic prediction of celiac disease targeting HLA-positive individuals.

Gad AbrahamAlexia RohmerJason A Tye-DinMichael Inouye
Published in: Genome medicine (2015)
Genomic risk scores for CD that target genetically at-risk sub-groups improve predictive performance beyond traditional approaches and may represent a useful strategy for prioritizing individuals at increased risk of disease, thus potentially reducing unnecessary follow-up diagnostic tests.
Keyphrases
  • celiac disease
  • copy number
  • cancer therapy
  • dna methylation
  • gene expression
  • drug delivery